Research map: Response to a Critique: Errors with Acri’s Opinion Piece Defending IP, While Premature Deaths Pile Up from Patents

Back to the article

Papers in this map

  1. Insulin Access and Affordability Working Group: Conclusions and Recommendations · William T. Cefalu · 2018 · 259 citations · Cited by this paper
  2. The Function of Non-invasive Prenatal Testing (NIPT) Request Forms in the Australian Context · 2025 · Related
  3. Cost-Related Insulin Underuse Among Patients With Diabetes · Darby Herkert · 2018 · 233 citations · Cited by this paper
  4. Therapeutic Misconception as a Problem of Nonmaleficence by Way of False Hope · 2026 · Related
  5. May your drug price be evergreen · Robin Feldman · 2018 · 105 citations · Cited by this paper
  6. Rethinking Health System Readiness for Frailty Management: Frontline Perspectives from Indonesia and Malaysia · 2026 · Related
  7. Why Is There No Generic Insulin? Historical Origins of a Modern Problem · Jeremy A. Greene · 2015 · 81 citations · Cited by this paper
  8. Advertising Ban in Healthcare: A Qualitative Study from the Perspective of Private Hospital Managers in Türkiye · 2026 · Related
  9. Production costs and potential prices for biosimilars of human insulin and insulin analogues · Dzintars Gotham · 2018 · 60 citations · Cited by this paper
  10. Responsive Equanimity to Uncertainty: Towards the Construction of a Concept for Handling Medical Uncertainty in Clinical Practice · 2026 · Related
  11. Costs and underuse of insulin and diabetes supplies: Findings from the 2020 T1International cross-sectional web-based survey · Elizabeth Pfiester · 2021 · 35 citations · Cited by this paper
  12. Clashing Perspectives? Two Approaches to the Desirability of Biological Aging · 2026 · Related
  13. Evolution of insulin patents and market exclusivities in the USA · Jing Luo · 2015 · 26 citations · Cited by this paper
  14. Hospitalizations at Home in Israel, a Retrospective Observational Study · 2025 · Related
  15. Comparing Insulin Prices in the United States to Other Countries: Results from a Price Index Analysis · Andrew W. Mulcahy · 2020 · 18 citations · Cited by this paper
  16. Design and Validation of an Instrument to Evaluate Cognitive-Physiological Repercussions and Coping Strategies in a Pandemic Situation · 2025 · Related
  17. Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019 · T. Anders Olsen · 2023 · 16 citations · Cited by this paper
  18. Collaboration During Crisis: New Graduates’ Experiences of Interprofessional Practice During the COVID-19 Pandemic · 2025 · Related
  19. Open-source 3-D printable autoinjector: Design, testing, and regulatory limitations · Anjutha Selvaraj · 2023 · 5 citations · Cited by this paper
  20. Quantitative Impacts of Normalizing Gluttony: Case Study of the USA · Joshua M. Pearce · 2024 · 2 citations · Cited by this paper
  21. Quantifying the Human Mortality Costs of Patent-based Intellectual Property: How Many Premature Deaths are due to Patents? · Joshua M. Pearce · 2025 · 1 citation · Cited by this paper
  22. Insulin Rationing Persists Despite Policy Changes: Repeated Cross-Sectional Studies, 2017 vs 2024 · Sefia Khan · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)